Investors
Mach7 Technologies (ASX: M7T) is a healthcare technology company founded in 2007. We build enterprise imaging software that helps hospitals and health systems consolidate, store and share medical images across their organisation — including our vendor neutral archive, the eUnity diagnostic viewer, and workflow tools spanning radiology, digital pathology, teleradiology and veterinary imaging.
Our software is used by healthcare providers worldwide.
Françoise Dixon
Head of Investor Relations
Mach7 Technologies Limited
Share Price
Investor Events
View all resources
FY26 Q4 Results Investor Webinar
In this recorded webinar, Teri Thomas, CEO and Managing Director, Shawni Hadfield, interim CFO, and Francoise Dixon, Head of Investor Relations, provide an update on Mach7’s Q4 ...
FY26 Q3 Results Investor Webinar
In this recorded webinar, Teri Thomas, CEO and Managing Director, Dan Lee, Mach7’s CFO, Todd Stallard, EVP Sales and Marketing, and Francoise Dixon, Head of Investor Relations, ...
FY26 First Half Results Investor Webinar
In this recorded webinar, Teri Thomas, CEO and Managing Director, Dan Lee, Mach7’s CFO, and Francoise Dixon, Head of Investor Relations, provide an update on Mach7’s 1st half ...
FY26 Q2 Results Investor Webinar
In this recorded webinar, Teri Thomas, CEO and Managing Director, Dan Lee, Mach7’s CFO, and Francoise Dixon, Head of Investor Relations, provide an update on Mach7’s Q2 Financial ...
FY26 Q1 Results Investor Webinar
In this recorded webinar, Teri Thomas, CEO and Managing Director, Dan Lee, Mach7’s new CFO, and Francoise Dixon, Head of Investor Relations, provide an update on Mach7’s Q1 ...
FY25 Annual Report to the Shareholders
Mach7’s Annual Report to its Shareholders for Fiscal Year 2025 (FY25) has been released.
Investor Information
Share Registry Corporate Governance Right to Receive Documents


